Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 44   

Articles published

TENX 3.79 -0.17 (-4.29%)
price chart
Small Cap IR Issues Tenax Therapeutics Analyst Report: Large Validated Market ...
NEW YORK, Nov. 25, 2014 /PRNewswire/ -- Analyst Report by Small Cap IR - Tenax Therapeutics, Inc. (NASDAQ: TENX) After a name change and a refocus of priorities the Company is poised to strengthen its position as an emerging providers of products for ...
News Recap - Tenax Therapeutics Inc (NASDAQ:TENX), Molycorp Inc (NYSE ...  Techsonian (press release)
Related articles »  
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics ...
�We are very pleased to unveil this new company name as we continue moving forward as Tenax Therapeutics,� said John Kelley, Chief Executive Officer.
Beleagured Morrisville drug developer changes name, sharpens focus  Triangle Business Journal
Related articles »  
Rarely Bears Walks In Biotech Industry- Galena Biopharma Inc (NASDAQ:GALE ...
Shares of Tenax Therapeutics Inc (NASDAQ:TENX) [Detail Analytic Report] plummeted with 1.25% to $3.96, as from the last 5 day average it increased to the peak of 7.03%, whereas its market volume is 5.16 million.
Related articles »  
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter ...
As a result, RA Capital Management is left holding 8.03 million shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In another move, the fund's manager, Peter Kolchinsky, has initiated a position in Tenax Therapeutics Inc (NASDAQ:TENX). According ...
Related articles »  
Stocks Ending Negative:Tenax Therapeutics Inc. , Equity Residential , Ultrapro ...
Shares of Tenax Therapeutics Inc. (NASDAQ:TENX) registered a depreciation in the share price at 1.25% or 0.05 points in their value.
Related articles »  
Tenax Therapeutics (TENX) Jumps: Stock Moves Up 7.8%
Tenax Therapeutics, Inc. (TENX) was a big mover last session, as its shares rose nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.
Related articles »  
Tenax Therapeutics to Provide Corporate Update and Discuss First Quarter ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., today announced that the Company will host a conference call and live audio webcast on Wednesday, September 24, 2014, at 8:30 ...
Related articles »  
Morning Most Volatile : RMG Networks Holding Corporation (RMGN), Tenax ...
Tenax Therapeutics, Inc. (TENX) of the Healthcare sector (Biotechnology) has gained 5.22% from open per share today. Tenax Therapeutics, Inc. (TENX) is currently at $4.23, with a market cap of 113 , a volume of 3,558,320 shares and a weekly performance ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q1 2015 Results - Earnings ...
Greetings and welcome to the Tenax Therapeutics First Quarter 2015 Earnings call. At this time, all participants are in a listen-only mode.
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results  Business Wire (press release)
Related articles »  
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS ...
MORRISVILLE, N.C., Sep 22, 2014 (BUSINESS WIRE) -- Tenax Therapeutics, Inc. TENX, -1.25% formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical ...
Morrisville's Tenax studies experimental drug in cardiac surgery patients  Triangle Business Journal
Related articles »